We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.

I Agree

You are here: Industry Insights > AstraZeneca

News List

AstraZeneca Siliq (brodalumab) approved by the US FDA for adult patients with moderate-to-severe pla worldpharmanews
February 17, 2017
AstraZeneca's partner Valeant Pharmaceuticals today announced that the US Food and Drug Administration (FDA) has approved Siliq (brodalumab) injection for the treatment of adult patients with moderate-to-severe plaque psoriasis who are candidates for syst
AstraZeneca awards grants for new programmes to improve heart health pharmaceutical-technology
February 10, 2017
AstraZeneca is awarding grants from its Connections for Cardiovascular Health programme to non-profit organisations that address the challenges of preventing and controlling cardiovascular disease by conducting programmes for at-risk groups.
AstraZeneca Releases Full-Year and Q4 2016 Results americanpharmaceuticalreview
February 06, 2017
Pascal Soriot, Chief Executive Officer, commenting on the results said:

Previous page 1 2 3 4 5 6 7 8 9 10 ... 80 81 Next page